2020
DOI: 10.1093/nar/gkaa1175
|View full text |Cite
|
Sign up to set email alerts
|

NGS-based identification and tracing of microsatellite instability from minute amounts DNA using inter-Alu-PCR

Abstract: Sensitive detection of microsatellite instability (MSI) in tissue or liquid biopsies using next generation sequencing (NGS) has growing prognostic and predictive applications in cancer. However, the complexities of NGS make it cumbersome as compared to established multiplex-PCR detection of MSI. We present a new approach to detect MSI using inter-Alu-PCR followed by targeted NGS, that combines the practical advantages of multiplexed-PCR with the breadth of information provided by NGS. Inter-Alu-PCR employs pol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 40 publications
0
18
0
Order By: Relevance
“…Considering that CODEC WGS showed 290-fold lower residual indel frequencies than standard WGS (Extended Data Fig. 9 ) and that Illumina NGS is known to have an especially high indel error rate at DNA homopolymers, we explored if CODEC might improve MSI detection, which is an FDA-approved indication for immunotherapy (anti-PD1/PDL1) but challenging to detect at low tumor fraction such as from liquid biopsies 40 . Indeed, CODEC WGS on NA12878 showed lower frequencies of both insertions and deletions at mononucleotide microsatellites than standard WGS (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering that CODEC WGS showed 290-fold lower residual indel frequencies than standard WGS (Extended Data Fig. 9 ) and that Illumina NGS is known to have an especially high indel error rate at DNA homopolymers, we explored if CODEC might improve MSI detection, which is an FDA-approved indication for immunotherapy (anti-PD1/PDL1) but challenging to detect at low tumor fraction such as from liquid biopsies 40 . Indeed, CODEC WGS on NA12878 showed lower frequencies of both insertions and deletions at mononucleotide microsatellites than standard WGS (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Plasma from DFCI protocol 05–055 (breast cancer, patient 95) 23 was derived from 10 to 20 cc whole blood in EDTA tubes. Snap-frozen colon adenocarcinoma stage II/III and paired normal tissue biopsies from treatment-naïve patient (MSI, patient 19) were obtained from the Massachusetts General Hospital Tumor Bank, and gDNA was extracted using the Blood and Tissue kit (QIAGEN, 69556) 40 . The sperm sample was obtained as part of an IRB-approved human subjects protocol at New York University Grossman School of Medicine 43 ( Supplementary Text ).…”
Section: Methodsmentioning
confidence: 99%
“…As Alu makes up 11% of the genome, this technique extended the previously published sensitivity of ctDNA in MSI testing by up to two orders of magnitude. In addition, it allowed the identification of MSI from a proportion of 0.05-0.15% of cfDNA [38].…”
Section: Discussionmentioning
confidence: 99%
“…The sequencing coverage as low as 0.05 × is sufficient for accurately calling the MSI status [ 191 ] Inter-Alu-PCR TGS NA This tool combines MNR enrichment and a custom MSI-tracer algorithm to compare the MNR’s read length. It can distinguish the cfDNA from cancer patients with MSI and samples from healthy individuals [ 192 ] Explanatory notes: Prog. Language , programming language; Ref.…”
Section: Current Methods Based On Liquid Biopsy For Msi Status Detectionmentioning
confidence: 99%